Business Description
Asston Pharmaceuticals Ltd
ISIN : INE0SJX01015
Compare
Compare
Traded in other countries / regions
544445.India IPO Date
2025-07-16Description
Asston Pharmaceuticals Ltd manufactures and exports pharmaceutical and nutraceutical products. The company produces a wide range of healthcare items including tablets, capsules, syrups, sachets, ointments, creams, gels, and lotions. It serves markets in West and South Africa, with expansions planned into Asian countries. Asston conducts business through export sales, contract manufacturing and loan license arrangements via merchant exporters, and domestic sales within India. Revenue is generated through the sale of branded and generic pharmaceutical formulations along with nutraceutical products. The business operations are broadly categorized into: Domestic Formulations, Export Formulations, APIs and Intermediates, and Research and Development.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.25 | |||||
Equity-to-Asset | 0.75 | |||||
Debt-to-Equity | 0.13 | |||||
Debt-to-EBITDA | 0.92 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 4.13 | |||||
Beneish M-Score | 0.07 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 61.6 | |||||
3-Year EBITDA Growth Rate | 41.4 | |||||
3-Year EPS without NRI Growth Rate | 58.3 | |||||
3-Year FCF Growth Rate | -238.2 | |||||
3-Year Book Growth Rate | 169.5 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 57.71 | |||||
9-Day RSI | 46.38 | |||||
14-Day RSI | 42.93 | |||||
3-1 Month Momentum % | -1.11 | |||||
6-1 Month Momentum % | -3.6 | |||||
12-1 Month Momentum % | -30.83 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.51 | |||||
Quick Ratio | 4.43 | |||||
Cash Ratio | 0.14 | |||||
Days Inventory | 14.74 | |||||
Days Sales Outstanding | 452.32 | |||||
Days Payable | 116.35 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 31.63 | |||||
Operating Margin % | -3.49 | |||||
Net Margin % | 15.18 | |||||
EBITDA Margin % | 21.79 | |||||
FCF Margin % | -79.48 | |||||
OCF Margin % | -39.97 | |||||
ROE % | 13.14 | |||||
ROA % | 8.97 | |||||
ROIC % | -2.03 | |||||
3-Year ROIIC % | -5.24 | |||||
ROC (Joel Greenblatt) % | 17.95 | |||||
ROCE % | 16.28 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 13.12 | |||||
PE Ratio without NRI | 13.12 | |||||
PS Ratio | 1.82 | |||||
PB Ratio | 1.41 | |||||
Price-to-Tangible-Book | 1.47 | |||||
EV-to-EBIT | 11.64 | |||||
EV-to-EBITDA | 10.97 | |||||
EV-to-Revenue | 2.39 | |||||
EV-to-FCF | -2.89 | |||||
Price-to-Graham-Number | 0.94 | |||||
| Price-to-Net-Current-Asset-Value | 2.05 | |||||
Earnings Yield (Greenblatt) % | 8.6 | |||||
FCF Yield % | -35.49 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Asston Pharmaceuticals Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 254.688 | ||
| EPS (TTM) (₹) | 4.92 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 37.04 | ||
| 14-Day RSI | 42.93 | ||
| 14-Day ATR (₹) | 2.802303 | ||
| 20-Day SMA (₹) | 69.249 | ||
| 12-1 Month Momentum % | -30.83 | ||
| 52-Week Range (₹) | 60 - 123 | ||
| Shares Outstanding (Mil) | 8.51 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Asston Pharmaceuticals Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Asston Pharmaceuticals Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Asston Pharmaceuticals Ltd Frequently Asked Questions
What is Asston Pharmaceuticals Ltd(BOM:544445)'s stock price today?
The current price of BOM:544445 is ₹67.00. The 52 week high of BOM:544445 is ₹123.00 and 52 week low is ₹60.00.
When is next earnings date of Asston Pharmaceuticals Ltd(BOM:544445)?
The next earnings date of Asston Pharmaceuticals Ltd(BOM:544445) is .
Does Asston Pharmaceuticals Ltd(BOM:544445) pay dividends? If so, how much?
Asston Pharmaceuticals Ltd(BOM:544445) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Asston Pharmaceuticals Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers